Article Text

Download PDFPDF
Aripiprazole reduces acute mania compared with haloperidol in bipolar I disorder and causes fewer adverse effects

Statistics from Altmetric.com

Footnotes

  • For correspondence: Dr Eduard Vieta, Director of Research, Clinical Institute of Neuroscience, Hospital, Clinic, University of Barcelona, Barcelona, Spain; evieta{at}clinic.ub.es

  • Sources of funding: Bristol-Myers Squibb Company, Princeton, New Jersey, USA and Otsuka Pharmaceutical Co Ltd, Tokyo, Japan

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.